NCT03617679 2026-02-23
Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer
University of Colorado, Denver
Phase 2 Active not recruiting
Clinical Trials
70 trialsNCT03120624 2026-02-04
VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer
Mayo Clinic
Phase 1 Active not recruiting
NCT05082025 2026-01-09
Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT03671811 2026-01-06
Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy
City of Hope Medical Center
Phase 2 Active not recruiting
NCT03466788 2025-12-18
EndoQOL
Centre Francois Baclesse
Phase NA Completed
NCT01068249 2025-11-18
Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04025229 2025-10-15
High Intensity Interval Training in Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Phase NA Completed
NCT05263492 2025-10-02
Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer
Virginia Commonwealth University
Phase 2 Terminated
NCT05036681 2025-09-17
A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT02912572 2025-07-10
Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer
Dana-Farber Cancer Institute
Phase 2 Active not recruiting
NCT02899793 2025-06-11
Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer
Yale University
Phase 2 Completed
NCT03694262 2025-05-30
EndoBARR
Medical College of Wisconsin
Phase 2 Active not recruiting
NCT03835819 2025-05-15
A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC)
Dana-Farber Cancer Institute
Phase 2 Active not recruiting
NCT05737745 2025-05-09
FitEx for Endometrial Cancer Survivors: Initial Efficacy
Carilion Clinic
Phase NA Completed
NCT04514692 2025-04-23
Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging
Stanford University
Phase 1/2 Terminated
NCT04697264 2025-03-30
Adipocytokines in Endometrial Cancer
University of Surrey
Completed
NCT00513786 2025-03-28
Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT05796518 2025-03-28
Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors
Wake Forest University Health Sciences
Phase NA Completed
NCT04696276 2025-03-26
ERAS
University of West Attica
Phase NA Completed
NCT04750941 2025-03-04
Study of Copanlisib and Ketogenic Diet
Columbia University
Phase 2 Terminated
NCT02630823 2025-01-03
MK-3475 Immunotherapy in Endometrial Carcinoma
Washington University School of Medicine
Phase 1 Completed
NCT03241745 2024-12-27
A Study of Nivolumab in Selected Uterine Cancer Patients
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT02035787 2024-12-18
Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients
UNC Lineberger Comprehensive Cancer Center
Phase 2 Completed
NCT03207126 2024-11-25
Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy?
Imperial College London
Phase NA Completed
NCT02431676 2024-08-28
SPIRIT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT04743999 2024-03-29
Evaluation of Outcomes in Women Undergoing Multimodality Treatment for Advanced Stage Endometrial Carcinoma
Henry Ford Health System
Phase 2 Terminated
NCT03189446 2024-03-08
Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer
University of Oklahoma
Phase 2 Completed
NCT02728830 2024-02-21
A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
Duke University
Phase EARLY_PHASE1 Completed
NCT03476798 2024-02-15
Clovis-001
University of Oklahoma
Phase 2 Completed
NCT03015129 2024-02-06
A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT04511026 2023-10-11
Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer
Stanford University
Phase 2 Terminated
NCT01367002 2023-05-17
Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer
Yale University
Phase 2 Completed
NCT03642990 2023-04-12
NR in Chemo-induced Peripheral Neuropathy
University of Iowa
Phase 2 Terminated
NCT01818739 2023-03-22
Lymph Node Mapping in Patients With Endometrial Cancer
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT02549989 2023-02-22
Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT02549209 2022-03-02
Pembro/Carbo/Taxol in Endometrial Cancer
Big Ten Cancer Research Consortium
Phase 2 Completed
NCT01979003 2022-02-24
Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion
University of Arkansas
Phase EARLY_PHASE1 Completed
NCT03722030 2021-08-13
Telehealth-Based Resistance Training Intervention for Endometrial Cancer Survivors
University of Wisconsin, Madison
Phase NA Completed
NCT03572478 2021-03-09
Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer
University of Chicago
Phase 1/2 Terminated
NCT02506816 2020-11-30
Polen
MedSIR
Completed
NCT01939028 2020-08-27
Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery
Case Comprehensive Cancer Center
Phase NA Terminated
NCT00542490 2020-08-21
Vaginal Cuff Brachytherapy Followed by Chemotherapy in Patients With Endometrioid Cancer
University of Oklahoma
Phase 2 Completed
NCT03207074 2020-07-14
Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue?
Imperial College London
Phase NA Completed
NCT03813719 2020-07-14
Anxiety and Distress Levels in Women With Suspected Endometrial Cancer
Imperial College London
Completed
NCT02433080 2020-05-19
DEUS
University College, London
Phase NA Completed
NCT01705288 2020-02-17
Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
Masonic Cancer Center, University of Minnesota
Phase EARLY_PHASE1 Completed
NCT02068820 2019-09-10
Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG
AdventHealth
Phase NA Completed
NCT00319748 2019-08-26
Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers
Masonic Cancer Center, University of Minnesota
Phase 2 Completed
NCT02907073 2019-05-17
Positron Emission Tomography (PET) Imaging Studies With NIS Reporter
Mayo Clinic
Phase 1/2 Terminated
NCT01717391 2019-03-26
[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers
University of Iowa
Phase 2 Completed